← Back to patent-cliff list
CAS 38941-29-6
N-(2-methylbenzyl)-4,5-dihydro-1H-imidazol-2-amine
Codes: TIC-10-004
Application context (from source-drug indications)
Diffuse midline gliomaDordaviproneGliomaDordaviproneDiffuse intrinsic pontine gliomaDordaviproneBreast cancerDordaviprone三阴性乳腺癌DordaviproneEndometrial cancerDordaviprone
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Dordaviprone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(methylthio)-4,5-dihydro-1H-imidazole hydroiodide→methyl 2-(methylthio)-4,5-dihydro-1H-imidazole-1-carboxylate→o-tolylmethanamine→N-(2-methylbenzyl)-4,5-dihydro-1H-imidazol-2-amine→methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.